Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.53 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.53 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.53 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 3/20 | 0.50 |
| ▸ | CA12 | O43570 | 1/20 | 0.46 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.46 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.46 |
| ▸ | CA4 | P22748 | 1/20 | 0.46 |
| ▸ | CA6 | P23280 | 1/20 | 0.46 |
| ▸ | CA5A | P35218 | 1/20 | 0.46 |
| ▸ | CA7 | P43166 | 1/20 | 0.46 |
| ▸ | CA9 | Q16790 | 1/20 | 0.46 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.46 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL37382 | 0.83 | ALDH1A1 (0.68) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL3829279 | 0.83 | ALDH1A1 (0.58) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL5793033 | 0.83 | ALDH1A1 (0.53) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL11496004 | 0.82 | ALDH1A1 (0.49) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL11496008 | 0.82 | ALDH1A1 (0.49) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL20165793 | 0.81 | HCAR2 (0.56) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| SCHEMBL29327549 | 0.81 | ALDH1A1 (0.52) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| Ammonia Solution, Strong SCHEMBL9998884 | 0.81 | ALDH1A1 (0.65) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| Bicarbonate SCHEMBL29183459 | 0.81 | ALDH1A1 (0.65) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 | |
| Water SCHEMBL8217838 | 0.81 | ALDH1A1 (0.65) | ALDH1A1TDP1MAPK1L3MBTL1SLC6A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 72 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-111646982-A | Synthesis method of norketotifen | 浙江凯普化工有限公司 | 2020-09-11 | — | — | CN | claimed |
| CN-108409814-A | A kind of preparation method of Etimicin Sulfate | 福安药业集团宁波天衡制药有限公司 | 2018-08-17 | — | — | CN | claimed |
| EP-0511600-A2 | Long chain carboxylic acid imide ester | KURARAY CO., LTD. (JP) | 1992-11-04 | — | — | EP | claimed |
| US-20260122681-A1 | Coordinated Beamforming Sounding Exchange Framework | APPLE INC (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260122588-A1 | Coordinated Data Frame Exchange Sequence | APPLE INC (US) | 2026-04-30 | — | — | US | disclosed |
| US-12287336-B2 | Protein for rapid, efficient capture of antigens | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2025-04-29 | — | — | US | disclosed |
| WO-2025027576-A2 | RNA COMPOSITIONS TARGETING HIV | BioNTech SE (DE) | 2025-02-06 | — | — | WO | disclosed |
| CN-113248508-B | N-protected heterocyclic compounds, process for their preparation and process for their use in the preparation of C-nucleoside derivatives | 安徽诺全药业有限公司 | 2024-12-06 | — | — | CN | disclosed |
| CN-117493723-A | Digital-analog separation webpage end lightweight display method for grid GIM (graphics information module) file | 中国能源建设集团天津电力设计院有限公司 | 2024-02-02 | — | — | CN | disclosed |
| US-20230305002-A1 | PROTEIN FOR RAPID, EFFICIENT CAPTURE OF ANTIGENS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-09-28 | — | — | US | disclosed |
| US-11740236-B2 | Protein for rapid, efficient capture of antigens | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2023-08-29 | — | — | US | disclosed |
| US-5369108-A | Antitumor | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1994-11-29 | — | — | US | disclosed |
| US-5336782-A | N-(carboxyalkoyloxy)succinimides; modifiers of proteins and enzymes to prolong their plasma half-lives; nontoxic; antitumor and -carcinogenic agents | KURARAY CO., LTD. (JP) | 1994-08-09 | — | — | US | disclosed |
| EP-0136721-B1 | Carboxyalkenamidocephalosporins | SHIONOGI & CO (JP) | 1993-12-29 | — | — | EP | disclosed |
| WO-1993007148-A1 | NOVEL POTENT INDUCERS OF TERMINAL DIFFERENTIATION AND METHODS OF USE THEREOF | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1993-04-15 | — | — | WO | disclosed |
| EP-0511600-A2 | Long chain carboxylic acid imide ester | KURARAY CO., LTD. (JP) | 1992-11-04 | — | — | EP | disclosed |
| US-4912224-A | Containing a aminothiazolyl or aminothiadiazolyl ring | SHIONOGI & CO., LTD. (JP) | 1990-03-27 | — | — | US | disclosed |
| US-4748170-A | Carboxyalkenamidocephalosporins | SHIONOGI & CO., LTD. (JP) | 1988-05-31 | — | — | US | disclosed |
| US-4634697-A | Carboxyalkenamidocephalosporins | SHIONOGI & CO., LTD. (JP) | 1987-01-06 | — | — | US | disclosed |
| EP-0136721-A2 | Carboxyalkenamidocephalosporins | SHIONOGI & CO., LTD. (JP) | 1985-04-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230305002-A1 | PROTEIN FOR RAPID, EFFICIENT CAPTURE OF ANTIGENS | CD2BP2, HSPBP1, CD74 | ALDH1A1 4709/4885TDP1 2527/4885MAPK1 4226/4885 |
| US-12287336-B2 | Protein for rapid, efficient capture of antigens | CD2BP2, HSPBP1, CD74 | ALDH1A1 4709/4885TDP1 2527/4885MAPK1 4226/4885 |
| US-20260122588-A1 | Coordinated Data Frame Exchange Sequence | SARAF, ATM, STAT1 | ALDH1A1 3358/4885TDP1 2357/4885MAPK1 1839/4885 |
| US-11740236-B2 | Protein for rapid, efficient capture of antigens | CD2BP2, HSPBP1, CD74 | ALDH1A1 4709/4885TDP1 2527/4885MAPK1 4226/4885 |
| US-20260122681-A1 | Coordinated Beamforming Sounding Exchange Framework | ATM, STAT1, IRF2BP2 | ALDH1A1 3230/4885TDP1 795/4885MAPK1 3421/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.